Nivel 4 ATC
L01XC - Monoclonal antibodies
3 medicamente în această clasă
Subgrupe
L01XC01 Edrecolomab
L01XC02 Rituximab
L01XC03 Trastuzumab
L01XC05 Gemtuzumab Ozogamicin
L01XC06 Cetuximab
L01XC07 Bevacizumab
L01XC08 Panitumumab
L01XC09 Catumaxomab
L01XC10 Ofatumumab
L01XC11 Ipilimumab
L01XC12 Brentuximab Vedotin
L01XC13 Pertuzumab
L01XC14 Trastuzumab Emtansine
L01XC15 Obinutuzumab
L01XC16 Dinutuximab Beta
1 L01XC17 Nivolumab
L01XC18 Pembrolizumab
L01XC19 Blinatumomab
1 L01XC21 Ramucirumab
L01XC22 Necitumumab
L01XC23 Elotuzumab
L01XC24 Daratumumab
L01XC25 Mogamulizumab
L01XC26 Inotuzumab Ozogamicin
L01XC27 Olaratumab
L01XC28 Durvalumab
L01XC29 Bermekimab
L01XC31 Avelumab
1 L01XC32 Atezolizumab
L01XC33 Cemiplimab
L01XC34 Moxetumomab Pasudotox
L01XC35 Tafasitamab
L01XC36 Enfortumab Vedotin
L01XC37 Polatuzumab Vedotin
L01XC38 Isatuximab
L01XC39 Belantamab Mafodotin
L01XC40 Dostarlimab
L01XC41 Trastuzumab Deruxtecan
Clase înrudite
L01XA Platinum compounds L01XB Methylhydrazines L01XD Sensitizers used in photodynamic/radiation therapy L01XE (l01xe) L01XF Retinoids for cancer treatment L01XG Proteasome inhibitors L01XH Histone deacetylase (HDAC) inhibitors L01XJ Hedgehog pathway inhibitors L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors L01XL (l01xl) L01XM (l01xm) L01XX Other antineoplastic agents L01XY Combinations of antineoplastic agents